Health

Amneal Pharmaceutical LLC Issues a Nationwide Recall of Ropivacaine Hydrochloride Injection, USP 500mg/100mL, Due to the Potential Presence of Particulate Matter

DailyTrendDailyTrend
Apr 18, 2025 - 23:00
 0  2
Amneal Pharmaceutical LLC Issues a Nationwide Recall of Ropivacaine Hydrochloride Injection, USP 500mg/100mL, Due to the Potential Presence of Particulate Matter
Bridgewater, NJ, Amneal Pharmaceutical LLC, is recalling two lots of Ropivacaine Hydrochloride Injection, USP, 500mg/100mL, Infusion bags to the hospital/user level as the products may contain an inert fiber identified as polypropylene fibers from the IV bag.
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Bird Flu May Be Airborne on Dairy Farms, Scientists Report

Bird Flu May Be Airborne on Dairy Farms, Scientists Report

DailyTrend Aug 4, 2025  0  0

FDA is Requiring Opioid Pain Medicine Manufacturers to Update Prescribing Information Regarding Long-Term Use: Drug Safety Communication

FDA is Requiring Opioid Pain Medicine Manufacturers to ...

DailyTrend Aug 4, 2025  0  0

Sobi Announces U.S. Food and Drug Administration Approves Doptelet (avatrombopag) for the Treatment of Thrombocytopenia in Pediatric Patients One Year and Older with Persistent or Chronic Immune Thrombocytopenia (ITP)

Sobi Announces U.S. Food and Drug Administration Approv...

DailyTrend Jul 29, 2025  0  0

US FDA Approves New Biktarvy Indication For People With HIV Who Are Treatment Experienced And Restarting Antiretroviral Treatment

US FDA Approves New Biktarvy Indication For People With...

DailyTrend Aug 2, 2025  0  0

FDA Approves Vizz (aceclidine ophthalmic solution) for the Treatment of Presbyopia

FDA Approves Vizz (aceclidine ophthalmic solution) for ...

DailyTrend Aug 4, 2025  0  0

FDA Approves Alhemo as Once-Daily Prophylactic Treatment to Prevent or Reduce the Frequency of Bleeding Episodes for Adults and Children 12 Years of Age and Older with Hemophilia A or B (HA/HB) Without Inhibitors

FDA Approves Alhemo as Once-Daily Prophylactic Treatmen...

DailyTrend Aug 3, 2025  0  0